Atlas Trials

SK Life Science, Inc.

42 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch SK Life Science, Inc.

RecordFirmDate
Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy (NCT06453213)SK Life Science, Inc.2024-10-14
A Randomized, Open-label, Three-way Crossover Study to Evaluate the Relative Bioavailability of 200 Mg Cenobamate Administered Orally (NCT05572255)SK Life Science, Inc.2022-09-27
Safety, Tolerability, PK/PD & Preliminary Efficacy of SKL27969 in Advanced Solid Tumors Patients (NCT05388435)SK Life Science, Inc.2022-09-12
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults (NCT05219617)SK Life Science, Inc.2022-04-28
Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures (NCT05067634)SK Life Science, Inc.2022-01-14
Safety Study of Cenobamate in Subjects With Normal Hepatic Function and Subjects With Severe Hepatic Impairment (NCT04791553)SK Life Science, Inc.2021-06-17
Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures (NCT04903314)SK Life Science, Inc.2021-05-27
Bioavailability and Food Effect Study of Cenobamate as an Oral Suspension and Tablet (NCT04690751)SK Life Science, Inc.2020-12-21
Bioavailability and Food Effect Study of 3 Types of Carisbamate (NCT04520360)SK Life Science, Inc.2020-08-27
Single-Dose Escalation Study Followed by a Multiple-Dose Escalation Study of SKL24741 in Healthy Subjects (NCT04505397)SK Life Science, Inc.2020-02-13
Cenobamate Open-Label Extension Study for YKP3089C025 (NCT03961568)SK Life Science, Inc.2019-08-13
Carisbamate Safety Study in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome (NCT04062981)SK Life Science, Inc.2019-05-03
Carisbamate in Adult & Pediatric Subjects With Lennox-Gastaut Syndrome (NCT03731715)SK Life Science, Inc.2019-02-07
Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures (NCT03678753)SK Life Science, Inc.2018-10-03

Track SK Life Science, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.